1 d risk in Bartonella transmission to humans (bartonellosis).

2  an unusual clinical presentation for canine bartonellosis.

3 lysis using sera from patients with clinical bartonellosis.

4  a patient with the chronic verruga phase of bartonellosis.

5 formance as an aid in the diagnosis of acute bartonellosis.

6 t with the chronic, verruga peruana phase of bartonellosis.

7 r plating for the diagnostic confirmation of bartonellosis.

8  participants were monitored for evidence of bartonellosis.

9 nducted in a Peruvian community with endemic bartonellosis.

10              Bartonella bacilliformis causes bartonellosis, a potentially life-threatening emerging i

11                                   In humans, bartonellosis can result in angioproliferative lesions t

12 nt-phase sera, the IFA is positive in 93% of bartonellosis cases.

13 corresponded to the region of endemicity for bartonellosis; however, isolates belonging to two other

14                                      Age and bartonellosis in a family member were the best predictor

15 stigation was performed after an outbreak of bartonellosis in a region of Peru nonendemic for this di

16 uld be considered a diagnostic approach when bartonellosis is suspected.

17 -phase blood samples of laboratory-confirmed bartonellosis patients.

18 cifically associated with three outbreaks of bartonellosis that have recently occurred in areas where

19                Symptoms of acute and chronic bartonellosis were recorded.